Our ability to maintain attractive pricing and reimbursement levels for our products, in light of increasing competition, including from generic products, and pressure from government and other payers to decrease the costs associated with healthcare, including the potential impact of the Inflation Reduction Act of 2022 (IRA) on our business and President Trump’s most favored nation pricing initiative;
All entries for: United Therapeutics
October 29, 2025
United Therapeutics
Neutral Outlook
Silver Spring, MD
1,001-5,000 employees
Our ability to maintain attractive pricing and reimbursement levels for our products, in light of increasing competition, including from generic products, and pressure from government and other payers to decrease the costs associated with healthcare, including the potential impact of the Inflation Reduction Act of 2022 (IRA) on our business and President Trump’s most favored nation pricing initiative.
Disease Area: Cardiology, Rare Diseases, Respiratory Diseases
Drug Type: Biologic, Small Molecule